Browsing Tag
Avanzanite Bioscience
2 posts
Why Avanzanite’s hire of Dr. Mark Bechter could reshape how orphan drugs reach patients across 32 countries
Avanzanite Bioscience hires Dr. Mark Bechter as SVP medical affairs to drive rare disease growth, with H1 2025 revenues tripling. Learn more.
Avanzanite Bioscience secures EC approval for AKANTIOR as first authorised treatment for acanthamoeba keratitis
The European Commission (EC) has granted marketing authorisation for AKANTIOR (polihexanide), the first and only approved treatment for…